Present position: Research Director, Molecular Radiopharmacy, INRASTES, NCSR «Demokritos».

Previous Studies and Experience:

• 1995 – now: Researcher at NCSR «Demokritos» (NCSRD).
• 1992 – 1994: Visiting Scholar, Pharmacy Department, University of Padova, Italy
• 1992 : Visiting Scholar, Department of Nuclear Medicine, Ferrara University, Italy
• 1990-1991: Postdoc at the Institute of Nuclear Medicine, Basel University Hospital, Switzerland
• 1989-1990: Postdoc at the Department of Chemistry, University of Cincinnati, Cincinnati/OH, USA
• 1984-1989: PhD in Pharmaceutical Chemistry, Pharmacy School, University of Athens, Athens, Greece
• 1983-1985: Specialization in Radiopharmacy, Postgraduate School of I/R-RP, NCSRD, Athens, Greece
• 1982-1983: Research fellow of the National Institution of Research at the Department of Inorganic Chemistry, University of Patras, Patras, Greece
• 1978-1982: Diploma in Pharmacy, Pharmacy School, University of Patras, Patras, Greece

Research Activities:

In her present position and for more than 25 years now, Dr. Maina-Nock has been guiding research activities aiming at the development and evaluation of a wide spectrum of radiolabeled peptides for application in targeted diagnostic imaging and radionuclide therapy – “theranostics” – of human tumors.

She has been actively involved in the implementation of national and European scientific projects and research networks related to novel peptide radiopharmaceuticals. She has been responsible for MS and PhD candidates completing their Thesis on related topics.

In addition to drawing public funds for research she has pursued connection with local and European industry and clinical partners. As a result, a solid number of peer-reviewed articles, book chapters (>150) and congress presentations (>300) have been publicly released, while distinct products of this research have been evaluated in well reputed European clinical centers.

In 2013, she and her team in collaboration with Erasmus MC received the prestigious “Marie Curie Award” (https://www.eanm.org/congresses-events/awards-grants/winners/) for their work on the “in situ” stabilization of radiopeptides in vivo by means of co-administration of key-protease inhibitors.

Link to Scopus:  https://www.scopus.com/authid/detail.uri?authorId=6701857597#top

Patents:

https://worldwide.espacenet.com/searchResults?submitted=true&locale=en_EP&DB=EPODOC&ST=advanced&TI=&AB=&PN=&AP=&PR=&PD=&PA=&IN=nock+maina&CPC=&IC=